101 related articles for article (PubMed ID: 2040106)
1. In vitro vascular responsiveness to norepinephrine in experimental portal hypertension.
Bomzon A; Jacob G; Lee SS; Meddings J
Clin Invest Med; 1991 Feb; 14(1):63-71. PubMed ID: 2040106
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular responses to serotonin in experimental liver disease.
Jacob G; Bishara B; Lee SS; Hilzenart N; Bomzon A
Hepatology; 1991 Dec; 14(6):1235-42. PubMed ID: 1959874
[TBL] [Abstract][Full Text] [Related]
3. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
J Hepatol; 1995 Sep; 23(3):341-7. PubMed ID: 8550999
[TBL] [Abstract][Full Text] [Related]
4. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
5. Portal hypertension increases vasoconstrictor responsiveness of rat aorta.
Connolly C; Cawley T; McCormick PA; Docherty JR
Clin Sci (Lond); 1999 Jan; 96(1):41-7. PubMed ID: 9857105
[TBL] [Abstract][Full Text] [Related]
6. Vascular nitric oxide production during the development of two experimental models of portal hypertension.
Gadano AC; Sogni P; Heller J; Moreau R; Bories PN; Lebrec D
J Hepatol; 1999 May; 30(5):896-903. PubMed ID: 10365818
[TBL] [Abstract][Full Text] [Related]
7. [Smooth muscle function of the portal vein in spontaneously hypertensive rats].
Pinelis VG; Manukhina EB; Markov KhM
Biull Eksp Biol Med; 1987 Mar; 103(3):284-6. PubMed ID: 3828502
[TBL] [Abstract][Full Text] [Related]
8. [Endothelium contributes to the decreased aortic contractility in response to norepinephrine in experimental septic rats].
Liu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Apr; 14(2):151-4. PubMed ID: 1535564
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
[TBL] [Abstract][Full Text] [Related]
10. Hypotension in experimental cirrhosis. Is loss of vascular responsiveness to norepinephrine the cause of hypotension in chronic bile-duct-ligated dogs?
Bomzon A; Binah O; Blendis LM
J Hepatol; 1993 Jan; 17(1):116-23. PubMed ID: 8445210
[TBL] [Abstract][Full Text] [Related]
11. Everted portal vein: a sensitive model for studies of vasoactive compounds.
Mastrangelo D; Mathison R
J Cardiovasc Pharmacol; 1983; 5(1):98-101. PubMed ID: 6186867
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of contractile response of isolated portal veins from chronic portal hypertensive rats under altered levels of external K+, Ca2+, and norepinephrine concentrations: a comparison with normal Wistar rats.
Yoshimura T; Arita M; Kobayashi M
Jpn J Physiol; 1988; 38(4):459-78. PubMed ID: 3236568
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
Coll M; Genescà J; Raurell I; Rodríguez-Vilarrupla A; Mejías M; Otero T; Oria M; Esteban R; Guardia J; Bosch J; Martell M
J Hepatol; 2008 Jul; 49(1):43-51. PubMed ID: 18457899
[TBL] [Abstract][Full Text] [Related]
14. Endothelial COX-1 and -2 differentially affect reactivity of MVB in portal hypertensive rats.
Potenza MA; Botrugno OA; De Salvia MA; Lerro G; Nacci C; Marasciulo FL; Andriantsitohaina R; Mitolo-Chieppa D
Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G587-94. PubMed ID: 12181171
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermia decreases the response to vasoconstrictors in rat portal veins.
Pastor CM
Eur J Pharmacol; 2004 Jun; 494(2-3):191-7. PubMed ID: 15212974
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in vascular reactivity of aortas from rats with and without portal hypertension.
Robert R; Chagneau-Derrode C; Carretier M; Mauco G; Silvain C
J Gastroenterol Hepatol; 2005 Jun; 20(6):890-4. PubMed ID: 15946136
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of phentolamine on the responsiveness of aortic and femoral smooth muscle from normotensive and DOCA/NaCl hypertensive rats.
Soltis EE; Soltis TD; Katovich MJ; Field FP
Artery; 1986; 13(6):325-39. PubMed ID: 3778217
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular hyporesponsiveness to norepinephrine, propranolol and nitroglycerin in portal-hypertensive and aged rats.
Polio J; Sieber CC; Lerner E; Groszmann RJ
Hepatology; 1993 Jul; 18(1):128-36. PubMed ID: 8325604
[TBL] [Abstract][Full Text] [Related]
19. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
20. The effect of bile duct manipulation and pair-feeding on peripheral vascular neuroeffector mechanisms: in vitro studies.
Said O; Bomzon A
J Pharmacol Toxicol Methods; 1995 Aug; 33(4):205-12. PubMed ID: 8527828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
